Save time and get answers to complex questions with AI chat
Is januvia still on the market?Dabrafenib and trametinib cost?What's the recommended schedule for lurbinectedin side effect checks?Dabrafenib mesylate when the patent is expiring in india?Cost promethazine price?
See the DrugPatentWatch profile for Dupixent
Dupixent is dupilumab, a monoclonal antibody (mAb), not a small-molecule drug. As such, it doesn’t have a simple “chemical structure” diagram like a typical drug. Its structure is that of a protein, specifically an IgG4-type antibody. Key points: - Type: Fully human IgG4 monoclonal antibody - Target: IL-4 receptor alpha (IL-4Rα) - Mechanism: Blocks IL-4 and IL-13 signaling - Size: About 147 kDa (two identical heavy chains and two identical light chains) - So, the “structure” you’d look for is a Y-shaped antibody with Fab regions for antigen binding and an Fc region Public structural data: - There isn’t a published, public 2D/3D structure diagram for dupilumab itself in a standard structure database (PDB). - If you need a 3D model, you can use generic IgG4 antibody structures or Fab/Fc fragments from IgG antibodies as a close model. - For exact sequence and structural details (which are often in patents or manufacturer disclosures), you’d check: - Patent documents related to dupilumab for heavy/light chain sequences and hinge region features - General antibody structure resources (e.g., PDBe/RCSB PDB for IgG4 models) - FDA labeling or the product’s technical documentation for pharmacological details If you’d like, I can help look up any available structural models or provide links to general IgG4 structures you can use as references.
Other Questions About Dupixent :